Skip to main content
Clinical Trials/CTRI/2014/03/004451
CTRI/2014/03/004451
Completed
Phase 4

Study on the impact of oral immunomodulator in the treatment of venereal warts

Dr RML Hospital New Delhi0 sites60 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients with genital/venereal warts
Sponsor
Dr RML Hospital New Delhi
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr RML Hospital New Delhi

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients with anogenital warts who have not received any topical treatment in last 4 weeks and any systemic therapy in last 12 weeks
  • 2\.Patients who are willing to give informed consent

Exclusion Criteria

  • 1\.Pregnant females
  • 2\.Extensive warts
  • 3\.Any topical treatment in last 4 weeks
  • 4\.Any systemic therapy in last 12 weeks
  • 5\.Giant condyloma acuminate
  • 6\.Immunocompromised patients including HIV positivity

Outcomes

Primary Outcomes

Not specified

Similar Trials